Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
format_facet:"Aufsätze"
topic_facet:"EC 2.7.10.1"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22EC+2.7.10.1%22&lookfor=%22Liu%2C+Xiaoqing%22&type=Person
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22EC+2.7.10.1%22&lookfor=%22Liu%2C+Xiaoqing%22&type=Person
Search /vufind/Search2/Results?filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22EC+2.7.10.1%22&lookfor=%22Liu%2C+Xiaoqing%22&type=Person
PubPharm (49)
1
Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib-refractory ALK-positive NSCLC from a phase II study
enthalten in:
Cancer communications (London, England)
| 2024
von
Zheng, J.
|
Wang, T.
|
Yang, Y.
| +41
Wird geladen...
2
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK-029A in Treatment-Naive Patients With Advanced NSCLC Harboring EGFR Exon 20 Insertion Mutations : A Phase 1 Trial
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2024
von
Duan, J.
|
Wu, L.
|
Yang, K.
| +32
Wird geladen...
3
Brigatinib Versus Alectinib in ALK-Positive NSCLC After Disease Progression on Crizotinib : Results of Phase 3 ALTA-3 Trial
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2023
von
Yang, J.
|
Liu, G.
|
Lu, S.
| +11
Wird geladen...
4
Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC
enthalten in:
Thoracic cancer
| 2023
von
Ma, X.
|
Zhang, K.
|
Xu, J.
| +6
Wird geladen...
5
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC
enthalten in:
The New England journal of medicine
| 2023
von
Tsuboi, M.
|
Herbst, R.
|
John, T.
| +118
CommentIn: Nat Rev Clin Oncol. 2023 Aug;20(8):504. - PMID 37311902
Wird geladen...
6
Radiomic-signature changes after early treatment improve the prediction of progression-free survival in patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer
enthalten in:
Acta radiologica (Stockholm, Sweden : 1987)
| 2023
von
Hou, D.
|
Zheng, X.
|
Song, W.
| +11
Wird geladen...
7
Safety and Efficacy of Epitinib for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases : Open-Label Multicentre Dose-Expansion Phase Ib Study
enthalten in:
Clinical lung cancer
| 2022
von
Zhou, Q.
|
Wang, M.
|
Zhang, H.
| +5
Wird geladen...
8
Efficacy of different sequential patterns after crizotinib progression in advanced anaplastic lymphoma kinase-positive non-small cell lung cancer
enthalten in:
Thoracic cancer
| 2022
von
Ma, X.
|
Yang, S.
|
Zhang, K.
| +6
Wird geladen...
9
Lorlatinib for Previously Treated ALK-Positive Advanced NSCLC : Primary Efficacy and Safety From a Phase 2 Study in People's Republic of China
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2022
von
Lu, S.
|
Zhou, Q.
|
Liu, X.
| +23
Wird geladen...
10
A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC : Final Analysis, with a Focus on Patients Enrolled at Sites in China
enthalten in:
Targeted oncology
| 2022
von
Tu, H.
|
Feng, J.
|
Shi, M.
| +26
Wird geladen...
1
2
3
4
5
Nächster »
[5]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Medienart: Aufsätze
Filter aufheben
Thema: EC 2.7.10.1
Medienart
Aufsätze
46
E-Artikel
46
E-Ressourcen
3
Gedruckte Aufsätze
Zeitschriftentitel
11
Zhongguo fei ai za zhi = Chinese journal of lun...
5
Journal of thoracic oncology : official publica...
5
Thoracic cancer
4
The Lancet. Respiratory medicine
2
Journal of clinical oncology : official journal...
2
Lung cancer (Amsterdam, Netherlands)
2
The New England journal of medicine
2
Zhonghua bing li xue za zhi = Chinese journal o...
1
ACS applied materials & interfaces
1
Acta radiologica (Stockholm, Sweden : 1987)
1
Annals of oncology : official journal of the Eu...
1
Cancer communications (London, England)
1
Cellular immunology
1
Clinica chimica acta; international journal of ...
1
Clinical lung cancer
1
Journal of cancer research and clinical oncology
1
Journal of clinical pathology
1
Oncotarget
1
PloS one
1
Signal transduction and targeted therapy
Alle anzeigen ...
weniger ...
Thema
EC 2.7.10.1
49
Journal Article
31
ErbB Receptors
27
Research Support, Non-U.S. Gov't
25
Protein Kinase Inhibitors
21
EGFR protein, human
18
Antineoplastic Agents
14
Anaplastic Lymphoma Kinase
13
Multicenter Study
12
Quinazolines
12
Randomized Controlled Trial
10
Clinical Trial, Phase II
10
Clinical Trial, Phase III
10
Gefitinib
10
S65743JHBS
9
53AH36668S
9
Crizotinib
6
9G6U5L461Q
6
ALK protein, human
6
Comparative Study
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
22
2020-
27
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
35
Englisch
14
Chinesisch
Haven't found what you're looking for?
Wird geladen...